Wisconsin SB 251: Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE)

Status: Failed to pass pursuant to Senate Joint Resolution 1 (as of 2026-03-23)

State: Wisconsin · Session: 2025 · Bill: SB 251

Sponsors: Dassler-Alfheim, Drake, Hesselbein, Keyeski, L. Johnson, Larson, Ratcliff, Roys, Spreitzer, Wirch

View Wisconsin SB 251 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.